US stock · Healthcare sector · Diagnostics & Research
Company Logo

Danaher Corporation

DHRNYSE

265.98

USD
+0.12
(+0.05%)
Market Closed
27.53P/E
24Forward P/E
1.38P/E to S&P500
193.713BMarket CAP
0.38%Div Yield
Upcoming Earnings
19 Apr-24 Apr
Shares Short
1/13/23
4.08M
Short % of Float
0.63%
Short % of Shares Outs.
0.56%
% Held by Insiders
10.96%
% Held by Institutions
80.80%
Beta
0.82
PEG Ratio
7.55
52w. high/low
303.82/233.71
Avg. Daily Volume
2.59M
Return %
Stock
S&P 500
1 year
(3.28)
(6.69)
3 years
59.86
24.70
5 years
158.31
43.94
Scale: |
High
Low
33.43
17.89
29.02
18.09
36.08
26.46
42.52
29.83
43.33
36.01
58.67
42.59
66.33
53.16
74.01
61.60
82.64
61.60
95.16
78.22
110.86
91.84
154.00
96.44
248.32
119.60
333.96
211.22
328.57
233.71
279.32
242.48
Currency: USD
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
Revenue per share
17.71
19.88
17.43
20.21
23.80
26.33
27.47
28.36
29.46
24.42
26.34
28.39
25.05
31.55
41.22
44.04
Earnings per share
2.20
2.06
1.80
2.74
3.21
3.45
3.87
3.70
4.81
3.69
3.58
3.78
4.21
5.16
9.00
9.94
FCF per share
2.38
2.61
2.51
2.86
3.39
4.26
4.36
4.50
4.54
4.24
4.11
4.80
4.64
7.67
9.89
10.31
Dividends per share
0.06
0.06
0.07
0.08
0.09
0.12
0.07
0.32
0.51
1.28
0.54
0.62
1.05
0.87
1.04
1.14
CAPEX per share
0.26
0.30
0.29
0.33
0.49
0.66
0.79
0.85
0.91
0.85
0.89
0.94
0.89
1.12
1.81
1.61
Book Value per sh.
14.60
15.36
18.13
20.99
25.00
27.43
32.16
33.29
33.94
33.28
37.88
40.27
42.34
56.31
63.21
70.08
Comm.Shares outs.
622
639
642
653
676
693
696
702
698
691
696
701
715
706
715
715
Avg. annual P/E ratio
13.2
13.2
13.0
11.0
11.6
11.6
12.8
15.8
13.8
20.2
24.0
26.8
31.7
35.7
30.3
27.2
P/E to S&P500
0.8
0.6
0.2
0.5
0.7
0.8
0.8
0.9
0.7
0.9
1.0
1.1
1.3
0.9
1.0
1.3
Avg. annual div. yield
0.2%
0.2%
0.3%
0.3%
0.2%
0.3%
0.2%
0.6%
0.8%
1.7%
0.6%
0.6%
0.8%
0.5%
0.4%
0.4%
Revenue (m)
11,026
12,697
11,185
13,203
16,091
18,260
19,118
19,914
20,563
16,882
18,330
19,893
17,911
22,284
29,453
31,471
Operating margin
15.8%
14.7%
13.8%
16.4%
16.3%
17.3%
17.1%
17.2%
16.9%
16.3%
16.5%
17.1%
18.3%
19.0%
25.3%
27.6%
Depreciation (m)
268
339
342
397
635
840
895
939
1,051
1,128
1,238
1,308
1,190
1,775
2,168
2,222
Net profit (m)
1,370
1,318
1,152
1,793
2,172
2,392
2,695
2,598
3,357
2,554
2,492
2,651
3,008
3,646
6,433
7,103
Income tax rate
25.8%
24.7%
19.2%
23.5%
20.9%
23.6%
24.4%
25.4%
21.8%
17.5%
16.0%
19.5%
26.4%
18.9%
16.5%
13.1%
Net profit margin
12.4%
10.4%
10.3%
13.6%
13.5%
13.1%
14.1%
13.0%
16.3%
15.1%
13.6%
13.3%
16.8%
16.4%
21.8%
22.6%
Working capital (m)
1,150
1,442
2,460
2,425
2,100
3,382
4,586
4,035
1,666
(209)
2,058
2,252
20,665
6,400
3,508
7,494
Long-term debt (m)
3,396
2,553
2,889
2,784
5,207
5,288
3,437
3,402
12,025
9,674
10,327
9,689
22,156
21,978
23,057
19,086
Equity (m)
9,086
9,809
11,630
13,711
16,905
19,017
22,385
23,378
23,690
23,003
26,358
28,214
30,271
39,766
45,167
50,082
ROIC
9.1%
9.6%
7.4%
10.0%
8.7%
8.7%
9.3%
8.5%
7.9%
6.9%
6.3%
6.5%
5.1%
5.6%
8.8%
9.6%
Return on capital
10.3%
10.7%
7.9%
11.1%
9.5%
9.9%
10.7%
9.8%
8.8%
7.1%
6.7%
7.2%
6.4%
6.3%
9.5%
10.0%
Return on equity
15.1%
13.4%
9.9%
13.1%
12.8%
12.6%
12.0%
11.1%
14.2%
11.1%
9.5%
9.4%
9.9%
9.2%
14.2%
14.2%
Plowback ratio
97.5%
97.1%
96.4%
97.1%
96.8%
96.2%
98.1%
91.2%
86.4%
58.9%
84.7%
83.7%
69.1%
83.1%
88.3%
88.7%
Div.&Repurch./FCF
(39.2)%
1.8%
(8.2)%
(6.8)%
(45.9)%
17.7%
(4.1)%
3.0%
3.3%
24.6%
10.8%
10.0%
(44.2)%
(23.4)%
9.3%
10.7%
Capital Structure
31 Dec · 2022 | Q4
All numbers in millions
Total liabilities
$ 34,268
Total assets
$ 84,350
Long-term debt
$ 19,086
Cash and equiv.
$ 5,995
Goodwill
$ 39,752
Retained earnings
$ 39,205
Common stock
729
Enterprise Value
$ 206,804
Working Capital
Currency: USD, in millions
2020
2021
2022
Cash & Investments
6,035
2,586
5,995
Receivables
4,045
4,631
4,918
Inventory
2,292
2,767
3,110
Other
1,430
(1,785)
1,820
Current assets
13,802
11,648
15,883
Acc. Payable
2,049
2,569
2,296
Debt due
200
215
591
Other
5,153
5,356
5,502
Current liabilities
7,402
8,140
8,389
Annual growth rates
(avg. rate of change)
1 year
5 years
10 years
Revenue
6.85%
13.37%
6.68%
Cash flow
4.29%
24.14%
12.09%
Earnings
10.42%
30.38%
14.13%
Dividends
10.24%
21.51%
65.09%
Book value
10.88%
15.78%
9.74%
Insider Trading
Type
Shares
Date
Stevens Raymond C
Exempt
2,230
01/25/23
Stevens Raymond C
Exempt
2,230
01/25/23
Stevens Raymond C
Sale
2,230
01/25/23
Stevens Raymond C
Exempt
2,640
01/25/23
Stevens Raymond C
Exempt
3,540
01/25/23
Quarterly Revenue
Currency: USD, in millions
Year
1Q
2Q
3Q
4Q
Total
2020
4,343
5,297
5,883
6,760
22,284
2021
6,858
7,218
7,229
8,148
29,453
2022
7,688
7,751
7,663
8,369
31,471
Earnings per share
Currency: USD
Year
1Q
2Q
3Q
4Q
Total
2020
0.84
1.31
1.25
1.76
5.16
2021
2.38
2.50
1.62
2.50
9.00
2022
2.41
2.35
2.20
3.09
10.06
Quarterly dividends paid
Currency: USD
Year
1Q
2Q
3Q
4Q
Total
2020
0.20
0.21
0.23
0.24
0.87
2021
0.24
0.27
0.27
0.27
1.04
2022
0.27
0.31
0.29
- -
- -
Company Description
Sector:
Healthcare
Industry:
Diagnostics & Research
CEO:
Mr. Thomas Joyce
Full-time employees:
78,000
City:
WASHINGTON
Address:
2200 Pennsylvania Ave NW Ste 800w
IPO:
Dec 10, 1969
Website:
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.